AccessClosure introduces the newest addition to the Mynx® Vascular Closure family, the Mynx M5. The M5 is a closure device that can be delivered directly through a small 5 French (5F) cardiovascular sheath without enlarging the arterial hole or traumatizing the surrounding tissue in the process. This "artery-friendly" approach also benefits hospitals as the M5 eliminates the need for a sheath exchange, which saves procedure time and expense. Additional features include:
- Diagnostic coronary and peripheral catheterization applications.
- Minimized discomfort due to its unique deployment method and sealant material.
- Use of a soft, bio-absorbable polymer material called polyethylene glycol (PEG), which has been used safely for over a decade in a wide range of medical products such as gel caps and eye drops.
- The ability for the sealant to be placed gently over the arterial puncture area during the procedure and immediately expand 3 to 4 times its original size by rapidly absorbing blood around the puncture site, which immediately stops the bleeding and seals the artery.
- The ability for the sealant to dissolve naturally within 30 days, leaving nothing behind inside, or on top of, the artery.
Access Closure, Inc., Corporate Headquarters, 645 Clyde Avenue, Mountain View, CA 94043.